Prevalence and metric of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis

…, M Kravtsenyuk, W Fung, L Eder, J Su… - Seminars in arthritis and …, 2020 - Elsevier
Objectives To systematically review and synthesize literature on 1) the overall prevalence of
depression and anxiety in SLE patients in identified studies, and 2) the pooled prevalence …

What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis

…, K Colosimo, J Medina-Rosas, A Mustafa, J Su… - Seminars in arthritis and …, 2018 - Elsevier
Objectives To systematically review the literature on the prevalence of Cognitive Dysfunction
(CD) in SLE patients in studies that used a specified neuropsychological instrument. …

The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus

H Jung, R Bobba, J Su, Z Shariati‐Sarabi… - Arthritis & …, 2010 - Wiley Online Library
Objective The antimalarial medication hydroxychloroquine has been proposed as a
thromboprotective agent in systemic lupus erythematosus (SLE), but studies thus far have been …

[HTML][HTML] Arteriovenous fistula outcomes in the era of the elderly dialysis population

CE Lok, MJ Oliver, J Su, C Bhola, N Hannigan… - Kidney international, 2005 - Elsevier
Arteriovenous fistula outcomes in the era of the elderly dialysis population. Background The
growth of patients ≥65 years on hemodialysis is increasing. Guidelines recommend …

Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based …

…, P Cheung, S Herschorn, R Saskin, J Su… - The lancet …, 2014 - thelancet.com
Background Studies of complications resulting from surgery or radiotherapy for prostate cancer
have mainly focused on incontinence and erectile dysfunction. We aimed to assess other …

Lack of association between the interferon-α signature and longitudinal changes in disease activity in systemic lupus erythematosus

…, A Lubovich, C Ferguson, T Unnithan, J Su… - Annals of the …, 2009 - ard.bmj.com
Objective: To study the longitudinal expression of interferon (IFN)-inducible genes in systemic
lupus erythematosus (SLE) and determine their suitability as disease biomarkers. Methods…

Peripheral neuropathy in patients with systemic lupus erythematosus

B Florica, E Aghdassi, J Su, DD Gladman… - Seminars in arthritis and …, 2011 - Elsevier
OBJECTIVE: In patients with systemic lupus erythematosus (SLE), to determine 1) the
prevalence and clinical features of peripheral neuropathies (PN) and whether they were SLE …

Utility of Urinary Protein‐Creatinine Ratio and Protein Content in a 24‐Hour Urine Collection in Systemic Lupus Erythematosus: A Systematic Review and Meta …

…, KS Yap, M Anderson, J Su… - Arthritis care & …, 2016 - Wiley Online Library
Objective To systematically review literature on the utility of spot urinary protein‐creatinine
ratio (PCR) as a screening test for proteinuria and its ability to accurately measure proteinuria …

The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus

PS Akhavan, J Su, W Lou, DD Gladman… - The Journal of …, 2013 - jrheum.org
Objective. To assess whether hydroxychloroquine (HCQ) prevents early damage in patients
with systemic lupus erythematosus (SLE). Methods. We updated an existing systematic …

All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971–2013)

K Tselios, DD Gladman, BJ Sheane, J Su… - Annals of the rheumatic …, 2019 - ard.bmj.com
Background Survival in systemic lupus erythematosus (SLE) has improved substantially in
the last 50 years. The aim of the present study was to assess the evolution of the all-cause, …